Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity

Human Mutation

Volumn 31, Issue 1, 2010, Pages 60-66

  Tchatchou, Sandrine ^a,b   Riedel, Angela ^c   Lyer, Stefan ^a   Schmutzhard, Julia ^a,b   Strobel Freidekind, Olga ^a   Gronert Sum, Sabine ^a   Mietag, Carola ^a   D'Amato, Mauro ^d   Schlehe, Bettina ^b   Hemminki, Kari ^a,d   Sutter, Christian ^b   Ditsch, Nina ^e   Blackburn, Anneke ^f   Hill, Linda Zhai ^g,o   Jerry, D Joseph ^g,o   Bugert, Peter ^b   Weber, Bernhard H F ^h   Niederacher, Dieter ⁱ   Arnold, Norbert ^j   Varon Mateeva, Raymonda ^k   Wappenschmidt, Barbara ^l   Schmutzler, Rita K ^l   Engel, Christoph ^m   Meindl, Alfons ⁿ   Bartram, Claus R ^b   Mollenhauer, Jan ^a,c   Burwinkel, Barbara ^a,b   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF MUNICH   (Germany)

^f Australian National University   (Australia)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^m UNIVERSITY OF LEIPZIG   (Germany)

ⁿ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^o Pioneer Valley Life Sciences Institute   (United States)

more..

Author keywords

Breast cancer risk; DMBT1 gene; DMBT1 polymorphisms; Risk factor

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RISK; CONTROL GROUP; CONTROLLED STUDY; DELETED IN MALIGNANT BRAIN TUMORS 1 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; RISK FACTORS;

MUS;

EID: 74049142035     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.21134     Document Type: Article

References (34)

1. Ace CI, Okulicz WC. 2005. The 5′ flanking region of the Rhesus monkey H3 (DMBT1) gene contains putative progesterone response elements. DNA Cell Biol 24:345-349.
2. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, et al. 2009. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41:585-590.
3. Antonarakis SE. 1998. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11:1-3.
4. Antoniou AC, Easton DF. 2003. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 25:190-202.
5. Balmain A, Gray J, Ponder B. 2003. The genetics and genomics of cancer. Nat Genet 33(Suppl):238-244.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
7. Bikker FJ, Ligtenberg AJ, Nazmi K, Veerman EC, van't Hof W, Bolscher JG, Poustka A, Nieuw Amerongen AV, Mollenhauer J. 2002. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem 277:32109-32115.
8. Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J, Nikolcheva T, Allard J, Peltz G, Otis CN, Cao QJ, Ricketts RS, Naber SP, Mollenhauer J, Poustka A, Malamud D, Jerry DJ. 2007. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol 170:2030-2041.
9. Braidotti P, Nuciforo PG, Mollenhauer J, Poustka A, Pellegrini C, Moro A, Bulfamante G, Coggi G, Bosari S, Pietra GG. 2004. DMBT1 expression is down-regulated in breast cancer. BMC Cancer 4:46.
10. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rodr?́guez R, Barbosa-Morais NL, Ponder BA; SEARCH, Low YL, Bingham S; EPIC, Haiman CA, Le Marchand L, and many others. 2009. Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18:1131-1139.
11. Frank B, Bermejo JL, Hemminki K, Klaes R, Bugert P, Wappenschmidt B, Schmutzler RK, Burwinkel B. 2005. Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 97:1012; author reply 1012-1013.
12. Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, Holmskov U. 2003. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol 285: L1066-L1076.
13. Lei H, Hemminki K, Johansson R, Altieri A, Enquist K, Henriksson R, Lenner P, Forsti A. 2007. Single nucleotide polymorphisms in the DMBT1 promoter and the progression of breast cancer. Int J Cancer 120:447-449.
14. Ligtenberg AJ, Veerman EC, Nieuw Amerongen AV, Mollenhauer J. 2007. Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol Chem 388:1275-1289.
15. Lualdi E, Chiariello E, Finocchiaro G. 2000. Identification of regulatory regions of the putative tumor suppressor gene DMBT1. Biochem Biophys Res Commun 270:673-675.
16. Meindl A. 2002. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472-480.
17. Milne RL, Benitez J, Nevanlinna H, Heikkinen T, Aittomaki K, Blomqvist C, Arias JI, Zamora MP, Burwinkel B, Bartram CR, Meindl A, Schmutzler RK, Cox A, Brock I, Elliott G, Reed MW, SoutheyMC, Smith L, Spurdle AB, and many others. 2009. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 101:1012-1018.
18. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poustka A. 1997. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 17:32-39.
19. Mollenhauer J, Holmskov U, Wiemann S, Krebs I, Herbertz S, Madsen J, Kioschis P, Coy JF, Poustka A. 1999. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene 18:6233-6240.
20. Mollenhauer J, Muller H, Kollender G, Lyer S, Diedrichs L, Helmke B, Holmskov U, Ligtenberg T, Herbertz S, Krebs I, Madsen J, Bikker F, Schmitt L, Wiemann S, Scheurlen W, Otto HF, von Deimling A, Poustka A. 2002. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chromosomes Cancer 35:242-255.
21. Mollenhauer J, Helmke B, Medina D, Bergmann G, Gassler N, Muller H, Lyer S, Diedrichs L, Renner M, Wittig R, Blaich S, Hamann U, Madsen J, Holmskov U, Bikker F, Ligtenberg A, Carlén A, Olsson J, Otto HF, O'Malley B, Poustka A. 2004. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes Chromosomes Cancer 39:185-194.
22. Mollenhauer J, End C, Renner M, Lyer S, Poustka A. 2007. DMBT1 as an archetypal link between infection, inflammation, and cancer. Immunologia 26:193-209.
23. Nathanson KL, Wooster R, Weber BL. 2001. Breast cancer genetics: what we know and what we need. Nat Med 7:552-556.
24. Paez JG, Lin M, Beroukhim R, Lee JC, Zhao X, Richter DJ, Gabriel S, Herman P, Sasaki H, Altshuler D, Li C, Meyerson M, Sellers WR. 2004. Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 32:e71.
25. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
26. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. 2002. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36.
27. Prakobphol A, Xu F, Hoang VM, Larsson T, Bergstrom J, Johansson I, Frängsmyr L, Holmskov U, Leffler H, Nilsson C, Borén T, Wright JR, Strömberg N, Fisher SJ. 2000. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem 275:39860-39866.
28. Renner M, Bergmann G, Krebs I, End C, Lyer S, Hilberg F, Helmke B, Gassler N, Autschbach F, Bikker F, Strobel-Freidekind O, Gronert-Sum S, Benner A, Blaich S, Wittig R, Hudler M, Ligtenberg AJ, Madsen J, Holmskov U, Annese V, Latiano A, Schirmacher P, Amerongen AV, D'Amato M, Kioschis P, Hafner M, Poustka A, Mollenhauer J. 2007. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease. Gastroenterology 133:1499-1509.
29. Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, Hellmig S, Nikolaus S, Folsch UR, Helmke B, Autschbach F, Schirmacher P, Kioschis P, Hafner M, Poustka A, Mollenhauer J, Schreiber S. 2007. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol 178:8203-8211.
30. Shephard ND, Abo R, Rigas SH, Frank B, Lin WY, Brock IW, Shippen A, Balasubramanian SP, Reed MW, Bartram CR, Meindl A, Schmutzler RK, Engel C, Burwinkel B, Cannon-Albright LA, Allen-Brady K, Camp NJ, Cox A. 2009. A breast cancer risk haplotype in the caspase-8 gene. Cancer Res 69:2724-2728.
31. Takito J, Al-Awqati Q. 2004. Conversion of ES cells to columnar epithelia by hensin and to squamous epithelia by laminin. J Cell Biol 166:1093-1102.
32. Vijayakumar S, Takito J, Hikita C, Al-Awqati Q. 1999. Hensin remodels the apical cytoskeleton and induces columnarization of intercalated epithelial cells: processes that resemble terminal differentiation. J Cell Biol 144:1057-1067.
33. Wong KK, Tsang YT, Shen J, Cheng RS, Chang YM, Man TK, Lau CC. 2004. Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. Nucleic Acids Res 32:e69.
34. Wooster R, Weber BL. 2003. Breast and ovarian cancer. N Engl J Med 348:2339-2347.